Hanson & Doremus Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.42M | Sell |
|
|||||
|
2025
Q2 | $3.56M | Sell |
|
|||||
|
2025
Q1 | $3.91M | Buy |
|
|||||
|
2024
Q4 | $3.69M | Buy |
|
|||||
|
2024
Q3 | $3.98M | Sell |
|
|||||
|
2024
Q2 | $3.87M | Buy |
|
|||||
|
2024
Q1 | $3.66M | Buy |
|
|||||
|
2023
Q4 | $3.35M | Buy |
|
|||||
|
2023
Q3 | $3.01M | Sell |
|
|||||
|
2023
Q2 | $3.37M | Sell |
|
|||||
|
2023
Q1 | $3.79M | Sell |
|
|||||
|
2022
Q4 | $5.62M | Buy |
|
|||||
|
2022
Q3 | $4.28M | Sell |
|
|||||
|
2022
Q2 | $5.16M | Sell |
|
|||||
|
2022
Q1 | $5.29M | Sell |
|
|||||
|
2021
Q4 | $6.03M | Sell |
|
|||||
|
2021
Q3 | $4.42M | Sell |
|
|||||
|
2021
Q2 | $4.17M | Sell |
|
|||||
|
2021
Q1 | $4.39M | Sell |
|
|||||
|
2020
Q4 | $4.51M | Buy |
|
|||||
|
2020
Q3 | $4.17M | Sell |
|
|||||
|
2020
Q2 | $3.78M | Sell |
|
|||||
|
2020
Q1 | $4.36M | Buy |
|
|||||
|
2019
Q4 | $4.66M | Buy |
|
|||||
|
2019
Q3 | $4.21M | Buy |
|
|||||
|
2019
Q2 | $5.02M | Sell |
|
|||||
|
2019
Q1 | $5.11M | Sell |
|
|||||
|
2018
Q4 | $5.34M | Sell |
|
|||||
|
2018
Q3 | $5.49M | Sell |
|
|||||
|
2018
Q2 | $4.57M | Sell |
|
|||||
|
2018
Q1 | $5.13M | Buy |
|
|||||
|
2017
Q4 | $4.76M | Buy |
|
|||||
|
2017
Q3 | $4.68M | Buy |
|
|||||
|
2017
Q2 | $4.26M | Sell |
|
|||||
|
2017
Q1 | $4.36M | Sell |
|
|||||
|
2016
Q4 | $4.26M | Sell |
|
|||||
|
2016
Q3 | $4.49M | Sell |
|
|||||
|
2016
Q2 | $4.76M | Sell |
|
|||||
|
2016
Q1 | $4.04M | Buy |
|
|||||
|
2015
Q4 | $4.23M | Buy |
|
|||||
|
2015
Q3 | $4.04M | Sell |
|
|||||
|
2015
Q2 | $4.32M | Sell |
|
|||||
|
2015
Q1 | $4.58M | Sell |
|
|||||
|
2014
Q4 | $4.14M | Buy |
|
|||||
|
2014
Q3 | $3.63M | Buy |
|
|||||
|
2014
Q2 | $3.6M | Sell |
|
|||||
|
2014
Q1 | $4.14M | Sell |
|
|||||
|
2013
Q4 | $4.07M | Sell |
|
|||||
|
2013
Q3 | $4.15M | Sell |
|
|||||
|
2013
Q2 | $4.06M | Buy |
|